Increased B Cell ADAM10 in Allergic Patients and Th2 Prone Mice.
ADAM10, as the sheddase of the low affinity IgE receptor (CD23), promotes IgE production and thus is a unique target for attenuating allergic disease. Herein, we describe that B cell levels of ADAM10, specifically, are increased in allergic patients and Th2 prone WT mouse strains (Balb/c and A/J). W...
Main Authors: | Lauren Folgosa Cooley, Rebecca K Martin, Hannah B Zellner, Anne-Marie Irani, Cora Uram-Tuculescu, Mohey Eldin El Shikh, Daniel H Conrad |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4416757?pdf=render |
Similar Items
-
Association of ADAM33 gene polymorphisms with allergic asthma
by: Mohammad Reza Zand Karimi, et al.
Published: (2014-09-01) -
Targeting ADAM10 in Cancer and Autoimmunity
by: Timothy M. Smith, et al.
Published: (2020-03-01) -
Follicular dendritic cells in health and disease
by: Mohey Eldin M El Shikh, et al.
Published: (2012-09-01) -
Differential gene expression in ADAM10 and mutant ADAM10 transgenic mice
by: Postina Rolf, et al.
Published: (2009-02-01) -
ADAM10 and ADAM17—Novel Players in Retinoblastoma Carcinogenesis
by: Dario Van Meenen, et al.
Published: (2022-10-01)